🇺🇸 FDA
Pipeline program

DMT210 Topical Gel 5%

DMT210-003

Phase 2 small_molecule completed

Quick answer

DMT210 Topical Gel 5% for Acne Rosacea is a Phase 2 program (small_molecule) at Dermata Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Dermata Therapeutics
Indication
Acne Rosacea
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials